Interviews

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

by Andrii Buvailo, PhD  (contributor )   •     

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# Biotech   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

The rapid convergence of artificial intelligence (AI) and synthetic biology (synbio) is set to revolutionize a multitude of industries, ranging from healthcare and agriculture to renewable energy and environmental remediation. The integration of AI's data-processing capabilities with synbio's genetic manipulation technologies heralds a new era of biological innovation, presenting both unprecedented opportunities and significant challenges.

#advertisement
AI in Drug Discovery Report 2025

Continue reading

This content available exclusively for BPT Mebmers

Topics: Biotech   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email